Inhibitors of Histone Deacetylases Are Weak Activators of the FMR1 Gene in Fragile X Syndrome Cell Lines

Figure 2

FMRP level of control (a) and FXS (b) cell lines after treatment with HDACs inhibitors.

(a)

(b)